| 前收市價 | 6.66 |
| 開市 | 6.59 |
| 買盤 | 6.61 x 200 |
| 賣出價 | 6.66 x 300 |
| 今日波幅 | 6.42 - 6.80 |
| 52 週波幅 | 6.42 - 21.42 |
| 成交量 | |
| 平均成交量 | 1,287,430 |
| 市值 | 555.232M |
| Beta 值 (5 年，每月) | 1.70 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -3.12 |
| 業績公佈日 | 無 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 32.13 |
Motley FoolAfter a Serious Setback, Is Verve Therapeutics a Buy?
There are a few silver linings at play here.
ZacksBiotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
Disc Medicine, Inc. (IRON) and Verve Therapeutics (VERV) fall on study updates.
ZacksVerve (VERV) Pauses Enrollment in Cholesterol Study, Stock Falls
Verve (VERV) stops enrollment in the phase Ib study of gene therapy candidate VERVE-10 to reduce disease-driving low-density lipoprotein cholesterol due to safety issues. Stock plunges on the news.
